Liberia-U.S. Clinical Research Partnership Opens Trial to Test Ebola Treatments

 In partnership with the Liberian government, the National Institute of Allergy and Infectious Diseases (NIAID) today launched a clinical trial to obtain safety and efficacy data on the investigational drug ZMapp as a treatment for Ebola virus disease. The study, which will be conducted in Liberia and the United States, is a randomized controlled trial enrolling adults and children with known Ebola virus infection.READ MORE OF THIS STORY

(Visited 42 times, 1 visits today)

Be the first to comment

Leave a Reply

Your email address will not be published.


*